Aspirin Intolerance: Does Desensitization Alter the Course of the Disease?

Immunology and Allergy Clinics of North America

Volumn 29, Issue 4, 2009, Pages 669-675

  Klimek, L ^a   Pfaar, O ^a  

^a Center for Rhinology and Allergy   (Germany)

Author keywords

Aspirin desensitization; Aspirin intolerance; Aspirin sensitive; Morbus samter; Nasal polyps; Samter triad

Indexed keywords

ACETYLSALICYLIC ACID; ICOSANOID; IMMUNOGLOBULIN E; LEUKOTRIENE; LEUKOTRIENE A4; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LIPOXYGENASE; LYSINE ACETYLSALICYLATE; PLACEBO; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ANAMNESIS; ANAPHYLAXIS; ARACHIDONIC ACID METABOLISM; ASTHMA; CLINICAL FEATURE; CLINICAL TRIAL; DESENSITIZATION; DISEASE COURSE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SENSITIVITY; ENDOSCOPIC POLYPECTOMY; HUMAN; ICOSANOID METABOLISM; NOSE POLYP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; RHINOSINUSITIS; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; CYCLOOXYGENASE 1; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LEUKOTRIENES; NASAL POLYPS;

EID: 70350365115     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2009.07.008     Document Type: Review

References (34)

1. Hirschberg V.G. Anaphylactoid reaction to aspirin (1902). (classical article). Allergy Proc 11 (1990) 249-252
2. Widal M.F., Abrami P., and Lenmoyez J. Anaphylaxie et idiosyncrasie. Presse Med 30 (1922) 189-192
3. Samter M., and Beers R.F. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 68 (1968) 975-983
4. Szczeklik A., and Stevenson D.D. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 111 (2003) 913-921
5. Babu K.S., and Salvi S. Aspirin and asthma. Chest 118 (2000) 1470-1478
6. Pfaar O., and Klimek L. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements. Curr Opin Allergy Clin Immunol 6 (2006) 161-166
7. Szczeklik A., Nizankowska E., and Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 16 3 (2000) 432-436
8. Szczeklik A., Sanak M., Niz E., et al. Aspirin intolerance and the cyclooxygenase-leukotriene pathways. Curr Opin Pulm Med 10 (2004) 51-56
9. Berges-Gimeno M.P., Simon R.A., and Stevenson D.D. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 89 5 (2002) 474-478
10. Szczeklik A., and Nizankowska E. Clinical features and diagnosis of aspirin-induced asthma. Thorax 55 Suppl 2 (2000) 42-44
11. Bachert C., Watelet J.B., Gevaert P., et al. Pharmacological management of nasal polyposis. Drugs 65 11 (2005) 1537-1552
12. Picado C., and Mullol J. The nose in aspirin-sensitive asthma. In: Szczeklik A., Gryglewski R.J., and Vane J. (Eds). Eicosanois, aspirin and asthma (1998), Marcel Dekker, New York 493-505
13. Pawliczak R., Lewandowska-Polak A., and Kowalski M.L. Pathogenesis of nasal polyps: an update. Curr Allergy Asthma Rep 6 (2005) 463-471
14. Min J.W., Jang A.S., Park S.M., et al. Comparison of plasma eotaxin family level in aspirin-induced and aspirin-tolerant asthma patients. Chest 128 5 (2005) 3127-3132
15. Molnar-Gabor E., Endreffy E., and Rozsasi A. HLA-DRB1, -DQA1, and -DQB1 genotypes in patients with nasal polyposis. Laryngoscope 110 3 Pt 1 (2000) 422-425
16. Kowalski M.L., Grzegorczyk J., Pawliczak R., et al. Decreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivity. Allergy 57 6 (2002) 493-500
17. Gosepath J., Brieger J., and Mann W.J. New immunohistologic findings on the differential role of cyclooxygenase 1 and cyclooxygenase 2 in nasal polyposis. Am J Rhinol 19 2 (2005) 111-116
18. Jantii-Alanco S., Holopainen E., and Malmberg H. Recurrence of nasal polyps after surgical treatment. Rhinology 8 (1989) 59-64
19. Milewski M., Mastalerz L., and Nizankowska E. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 101 (1998) 581-586
20. Stevenson D.D., and Simon R.A. Lack of cross-reactivity between rofecoxib and aspirin-sensitive patients with asthma. J Allergy Clin Immunol 108 (2001) 47-51
21. Albu S., Tomescu E., Mexca Z., et al. Recurrence rates in endonasal surgery for polyposis. Acta Otorhinolaryngol Belg 58 1 (2004) 79-86
22. Zeiss C.R., and Lockey R.F. Refractory period to aspirin in a patient with aspirin-induced asthma. J Allergy Clin Immunol 57 5 (1976) 440-448
23. Schmitz-Schumann M., Schaub E., and Virchow C. Inhalation provocation test with lysineacetylsalicylic acid in patients with analgetics-induced asthma. Prax Klin Pneumol 36 1 (1982) 17-21
24. Patriarca G., Schiavino D., Nucera E., et al. Prevention of relapse in nasal polyposis. Lancet 337 8755 (1991) 1488
25. Parikh A.A., and Scadding G.K. Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial. Laryngoscope 115 8 (2005) 1385-1390
26. Stevenson D.D., Simon R.A., and Mathison D.A. Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 66 (1980) 82-88
27. Stevenson D.D., Pleskow W.W., Simon R.A., et al. Aspirin-sensitive rhinosinusitis asthma: a double blind cross over study of treatment with aspirin. J Allergy Clin Immunol 73 (1984) 500-507
28. Sweet J., Stevenson D.D., Simon R.A., et al. Long-term effects of aspirin desensitization-treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol 85 (1990) 59-65
29. Stevenson D.D., Hankammer M.A., Mathison D.A., et al. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 98 4 (1996) 751-758
30. Berges-Gimeno P., Simon R.A., and Stevenson D.D. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 111 (2003) 180-186
31. Pfaar O., Spielhaupter M., Wrede H., et al. Aspirin desensitization on patients with aspirin intolerance and nasal polyps. a new therapeutic approach by the intravenous route. Allergologie 8 (2006) 322-331
32. Schaefer D., Lindenthal U., Wagner M., et al. Effect of prostaglandin E2 on eicosanoid release by human bronchial biopsy specimens from normal and inflamed mucosa. Thorax 51 9 (1996) 919-923
33. Szczeklik A., Gryglewski R., and Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1 (1975) 67-69
34. Christie P., Tagari P., Ford-Hutchinson A.W., et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 143 (1991) 1025-1029